Information ahead of the extraordinary general meeting to be held on 27 March 2024
On 26 February 2024, Biokraft International AB (publ), reg.no 556528-4733 (“Biokraft” or the “Company”), announced the intention to resolve on a rights issue to finance repurchase of its senior secured green bonds (the “Rights Issue”). Due to this, the Company convened an extraordinary general meeting to be held on 27 March 2024, to, among other things, authorise the board of directors to resolve on the Rights Issue. In connection with the announcement, it was stated that the subscription price in the intended Rights Issue was expected to be determined no later than one day before the extraordinary general meeting and be announced through a separate press release.
On 13 March 2024, 1Vision Biogas AB (“1Vision Biogas”) announced the outcome of the mandatory cash tender offer, which 1Vision Biogas made to the shareholders in the Company on 2 February 2024 (the “Offer”). Following the Offer, the Offeror controls a total of 41,498,279 shares in Biokraft, corresponding to approximately 95.2 per cent of the total number of shares and votes in Biokraft. 1Vision Biogas has also requested compulsory redemption of the remaining shares in the Company in accordance with the Swedish Companies Act. In the light of that, on 22 March 2024 the board of directors of Biokraft resolved, in accordance with 1Vision Biogas’ request, to apply for delisting of the Company’s shares from Nasdaq First North Premier Growth Market.
1Vision Biogas has, ahead of the extraordinary general meeting on 27 March 2024, informed that they will attend the meeting and vote against the proposal to authorise the board of directors in Biokraft to resolve on the Rights Issue.
Based on the above, the Company will not determine and make publish any subscription price in the intended Rights Issue and thus the Rights Issue will not be conducted.
This information was submitted, through the care of the above contact person, for publication on 26 March 2024 at 21:00 CET.
